Reilly Grace D, Mahkawnghta Awng Shar, Jelinek Pia L, De Livera Alysha M, Weiland Tracey J, Brown Chelsea R, Taylor Keryn L, Neate Sandra L, Jelinek George A, Marck Claudia H
Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Front Neurol. 2017 May 31;8:229. doi: 10.3389/fneur.2017.00229. eCollection 2017.
Multiple sclerosis (MS) is a major cause of disability and poor quality of life (QOL). Previous studies have shown differences in MS health outcomes between countries. This study aimed to examine the associations between international regions and health outcomes in people with MS. Self-reported data were taken from the Health Outcomes and Lifestyle In a Sample of people with Multiple Sclerosis online survey collected in 2012. The 2,401 participants from 37 countries were categorized into three regions: Australasia, Europe, and North America. Differences were observed between regions in disability, physical and mental health QOL, fatigue, and depression, but most of these disappeared after adjusting for sociodemographic, disease, and lifestyle factors in multivariable regression models. However, adjusted odds for disability were higher in Europe [odds ratio (OR): 2.17, 95% confidence interval (CI): 1.28 to 3.67] and North America (OR: 1.79, 95% CI: 1.28 to 2.51) compared to Australasia. There may be other unmeasured factors that vary between regions, including differences in access and quality of healthcare services, determining disability in MS. When assessing differences in MS health outcomes, lifestyle factors and medication use should be taken into consideration.
多发性硬化症(MS)是导致残疾和生活质量(QOL)低下的主要原因。先前的研究表明,不同国家的MS健康结局存在差异。本研究旨在探讨国际区域与MS患者健康结局之间的关联。自我报告数据取自2012年收集的多发性硬化症患者样本中的健康结局与生活方式在线调查。来自37个国家的2401名参与者被分为三个区域:澳大拉西亚、欧洲和北美。在残疾、身心健康QOL、疲劳和抑郁方面观察到区域间存在差异,但在多变量回归模型中对社会人口统计学、疾病和生活方式因素进行调整后,这些差异大多消失。然而,与澳大拉西亚相比,欧洲(优势比[OR]:2.17,95%置信区间[CI]:1.28至3.67)和北美的残疾调整优势更高(OR:1.79,95%CI:1.28至2.51)。可能存在其他区域间不同的未测量因素,包括医疗服务的可及性和质量差异,这些因素决定了MS患者的残疾情况。在评估MS健康结局的差异时,应考虑生活方式因素和药物使用情况。